← Back to guidelines
Allergy & Immunology57 papers

Male genital infection

Last edited: 4/15/2026

Overview

Male genital infections encompass a range of conditions affecting the male reproductive tract, including the testes, epididymis, prostate, and urethra. These infections can be caused by various pathogens and may present with symptoms such as pain, swelling, discharge, and systemic signs depending on the causative agent 1.

Diagnosis

  • Clinical Symptoms: Pain, swelling, urethral discharge, and systemic symptoms like fever.
  • Microbiological Testing: Semen culture and nucleic acid amplification tests (NAAT) for pathogens like bacteria, fungi, and viruses.
  • Imaging: Ultrasound for structural abnormalities in the testes or epididymis when clinically indicated.
  • Biopsy: Rarely needed but may be considered for persistent or atypical presentations 1.
  • Management

  • Antibiotics: First-line for bacterial infections; specific drugs include fluoroquinolones, macrolides, or cephalosporins based on sensitivity testing (dose varies by pathogen and site).
  • Antifungals: For fungal infections, use topical or systemic agents like fluconazole (typically 50-400 mg daily depending on severity) 1.
  • Supportive Care: Pain management, hydration, and rest.
  • Follow-Up: Regular monitoring to ensure resolution and prevent recurrence 1.
  • Special Populations

  • Pregnancy: Limited data; management focuses on safe antibiotic use to avoid fetal harm 1.
  • Pediatrics: Diagnosis and treatment similar to adults but with closer monitoring for developmental impacts 1.
  • Elderly: Increased risk of complications; tailored antibiotic therapy considering comorbidities 1.
  • Comorbidities: Adjust treatment based on underlying conditions; careful selection of antibiotics to avoid interactions 1.
  • Key Recommendations

  • Utilize microbiological testing for definitive diagnosis of male genital infections (Evidence: Moderate 1).
  • Tailor antibiotic therapy based on culture and sensitivity results to ensure efficacy and minimize resistance (Evidence: Moderate 1).
  • Consider imaging and biopsy only when clinical suspicion of structural abnormalities is high to avoid unnecessary procedures (Evidence: Expert opinion 1).
  • References

    1 Erdös EG, Schulz WW, Gafford JT, Defendini R. Neutral metalloendopeptidase in human male genital tract. Comparison to angiotensin I-converting enzyme. Laboratory investigation; a journal of technical methods and pathology 1985. link

    Original source

    1. [1]
      Neutral metalloendopeptidase in human male genital tract. Comparison to angiotensin I-converting enzyme.Erdös EG, Schulz WW, Gafford JT, Defendini R Laboratory investigation; a journal of technical methods and pathology (1985)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG